PDCD1 and classic Hodgkin lymphoma: The multiplex analysis of the TME could reveal which cells (eg, MDSCs, M2 macrophages, Tregs) and proteins (eg, PD‐L1, PD‐1) are limiting the efficacy of immunotherapy in individual cHL patients, and these results may guide the choice of a personalized treatment.